- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01693289
Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome
September 25, 2012 updated by: IBRAHIM ABD ELGAFOR, Zagazig University
Phase 1 Study of Efficacy of Combined Metformin-letrozole in Comparison With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome
the study compare the hormonal-metabolic and reproductive outcome between combined metformin-letrozole and ovarian drilling in clomiphene resistant women with polycystic syndrome
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
146
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zagazig, Egypt
- Zagazig University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 31 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- polycystic ovary syndrome
- infertility
- clomiphene citrate resistance
Exclusion Criteria:
- women with other causes of infertility as male factor or tubal factor, those with endocrine disorders as thyroid dysfunction and hyperprolactinemia women who received hormonal treatment or ovulation induction drugs 3 months prior to the study
- pregnancy during follow up
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Metformin plus letrozole
metformin :850mg tablets twice daily for 6 months letrozole :5mg tablets twice daily form day 3to7 of cycle
|
Other Names:
|
|
Experimental: ovarian drilling
bilateral diathermy ovarian drilling, four drills each ovary
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
hormonal and metabolic changes
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
reproductive outcome
Time Frame: 6months
|
6months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
September 23, 2012
First Submitted That Met QC Criteria
September 25, 2012
First Posted (Estimate)
September 26, 2012
Study Record Updates
Last Update Posted (Estimate)
September 26, 2012
Last Update Submitted That Met QC Criteria
September 25, 2012
Last Verified
September 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neoplasms
- Endocrine System Diseases
- Ovarian Cysts
- Cysts
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Polycystic Ovary Syndrome
- Hypoglycemic Agents
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Antineoplastic Agents
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormone Antagonists
- Aromatase Inhibitors
- Steroid Synthesis Inhibitors
- Estrogen Antagonists
- Letrozole
- Metformin
Other Study ID Numbers
- elsharkwy t
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Focus of Study
-
Linkoeping UniversityRyhov County HospitalCompletedFocus of StudySweden
-
Beijing Anzhen HospitalUnknown
-
King Saud UniversityUnknown
-
Gladwin, Mark, MDCompletedFocus of Study of Healthy AdultsUnited States
-
Arne AstrupCompletedFocus of Study: AppetiteDenmark
-
Winthrop University HospitalCompleted
-
Hospital General ValenciaRecruitingBrief Description of Focus of Study InsteadSpain
-
Tel-Aviv Sourasky Medical CenterEuropean UnionUnknownFocus of Study: Carriers of Resistant Enterobacteriaceae.Israel
-
Uludag UniversityCompletedConditions or Focus of StudyTurkey (Türkiye)
-
Ohio State UniversityUniversity of Hohenheim; Universidad de Costa RicaCompletedFocus of Study: Carotenoid AbsorptionUnited States, Costa Rica
Clinical Trials on metformin plus letrozole
-
Assiut UniversityRecruitingInfertility, FemaleEgypt
-
Cairo UniversityCompletedPolycystic Ovary Syndrome | InfertilityEgypt
-
ShionogiCompleted
-
Sihuan Pharmaceutical Holdings Group Ltd.UnknownDiabetes Mellitus, Type 2China
-
Brigham and Women's HospitalFood and Drug Administration (FDA)Completed
-
Beni-Suef UniversityCompleted
-
Laboratorios Silanes S.A. de C.V.Completed
-
University Magna GraeciaCompletedPolycystic Ovary Syndrome | AnovulationItaly
-
Brigham and Women's HospitalFood and Drug Administration (FDA)CompletedAdvanced Breast CancerUnited States
-
University Magna GraeciaCompletedPolycystic Ovary Syndrome | PregnancyItaly